Cargando…

Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition

BACKGROUND: Although immune activation is associated with HIV acquisition, the nature of inflammatory profiles that increase HIV risk, which may include responses to M. tuberculosis (Mtb) infection, are not well characterized. METHODS: We conducted a nested case-control study using cryopreserved sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Bender Ignacio, Rachel A., Long, Jessica, Saha, Aparajita, Nguyen, Felicia K., Joudeh, Lara, Valinetz, Ethan, Mendelsohn, Simon C., Scriba, Thomas J., Hatherill, Mark, Janes, Holly, Churchyard, Gavin, Buchbinder, Susan, Duerr, Ann, Shah, Javeed A., Hawn, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064099/
https://www.ncbi.nlm.nih.gov/pubmed/35503767
http://dx.doi.org/10.1371/journal.pone.0267729
_version_ 1784699295468879872
author Bender Ignacio, Rachel A.
Long, Jessica
Saha, Aparajita
Nguyen, Felicia K.
Joudeh, Lara
Valinetz, Ethan
Mendelsohn, Simon C.
Scriba, Thomas J.
Hatherill, Mark
Janes, Holly
Churchyard, Gavin
Buchbinder, Susan
Duerr, Ann
Shah, Javeed A.
Hawn, Thomas R.
author_facet Bender Ignacio, Rachel A.
Long, Jessica
Saha, Aparajita
Nguyen, Felicia K.
Joudeh, Lara
Valinetz, Ethan
Mendelsohn, Simon C.
Scriba, Thomas J.
Hatherill, Mark
Janes, Holly
Churchyard, Gavin
Buchbinder, Susan
Duerr, Ann
Shah, Javeed A.
Hawn, Thomas R.
author_sort Bender Ignacio, Rachel A.
collection PubMed
description BACKGROUND: Although immune activation is associated with HIV acquisition, the nature of inflammatory profiles that increase HIV risk, which may include responses to M. tuberculosis (Mtb) infection, are not well characterized. METHODS: We conducted a nested case-control study using cryopreserved samples from persons who did and did not acquire HIV during the multinational Step clinical trial of the MRKAd5 HIV-1 vaccine. PBMCs from the last HIV-negative sample from incident HIV cases and controls were stimulated with Mtb-specific antigens (ESAT-6/CFP-10) and analyzed by flow cytometry with intracellular cytokine staining and scored with COMPASS. We measured inflammatory profiles with five Correlates of TB Risk (CoR) transcriptomic signatures. Our primary analysis examined the association of latent Mtb infection (LTBI; IFNγ+CD4+ T cell frequency) or RISK6 CoR signature with HIV acquisition. Conditional logistic regression analyses, adjusted for known predictors of HIV acquisition, were employed to assess whether TB-associated immune markers were associated with HIV acquisition. RESULTS: Among 465 participants, LTBI prevalence (21.5% controls vs 19.1% cases, p = 0.51) and the RISK6 signature were not higher in those who acquired HIV. In exploratory analyses, Mtb antigen-specific polyfunctional CD4+ T cell COMPASS scores (aOR 0.96, 95% CI 0.77, 1.20) were not higher in those who acquired HIV. Two CoR signatures, Sweeney3 (aOR 1.38 (1.07, 1.78) per SD change) and RESPONSE5 (0.78 (0.61, 0.98)), were associated with HIV acquisition. The transcriptomic pattern used to differentiate active vs latent TB (Sweeney3) was most strongly associated with acquiring HIV. CONCLUSIONS: LTBI, Mtb polyfunctional antigen-specific CD4+ T cell activation, and RISK6 were not identified as risks for HIV acquisition. In exploratory transcriptomic analyses, two CoR signatures were associated with HIV risk after adjustment for known behavioral and clinical risk factors. We identified host gene expression signatures associated with HIV acquisition, but the observed effects are likely not mediated through Mtb infection.
format Online
Article
Text
id pubmed-9064099
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-90640992022-05-04 Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition Bender Ignacio, Rachel A. Long, Jessica Saha, Aparajita Nguyen, Felicia K. Joudeh, Lara Valinetz, Ethan Mendelsohn, Simon C. Scriba, Thomas J. Hatherill, Mark Janes, Holly Churchyard, Gavin Buchbinder, Susan Duerr, Ann Shah, Javeed A. Hawn, Thomas R. PLoS One Research Article BACKGROUND: Although immune activation is associated with HIV acquisition, the nature of inflammatory profiles that increase HIV risk, which may include responses to M. tuberculosis (Mtb) infection, are not well characterized. METHODS: We conducted a nested case-control study using cryopreserved samples from persons who did and did not acquire HIV during the multinational Step clinical trial of the MRKAd5 HIV-1 vaccine. PBMCs from the last HIV-negative sample from incident HIV cases and controls were stimulated with Mtb-specific antigens (ESAT-6/CFP-10) and analyzed by flow cytometry with intracellular cytokine staining and scored with COMPASS. We measured inflammatory profiles with five Correlates of TB Risk (CoR) transcriptomic signatures. Our primary analysis examined the association of latent Mtb infection (LTBI; IFNγ+CD4+ T cell frequency) or RISK6 CoR signature with HIV acquisition. Conditional logistic regression analyses, adjusted for known predictors of HIV acquisition, were employed to assess whether TB-associated immune markers were associated with HIV acquisition. RESULTS: Among 465 participants, LTBI prevalence (21.5% controls vs 19.1% cases, p = 0.51) and the RISK6 signature were not higher in those who acquired HIV. In exploratory analyses, Mtb antigen-specific polyfunctional CD4+ T cell COMPASS scores (aOR 0.96, 95% CI 0.77, 1.20) were not higher in those who acquired HIV. Two CoR signatures, Sweeney3 (aOR 1.38 (1.07, 1.78) per SD change) and RESPONSE5 (0.78 (0.61, 0.98)), were associated with HIV acquisition. The transcriptomic pattern used to differentiate active vs latent TB (Sweeney3) was most strongly associated with acquiring HIV. CONCLUSIONS: LTBI, Mtb polyfunctional antigen-specific CD4+ T cell activation, and RISK6 were not identified as risks for HIV acquisition. In exploratory transcriptomic analyses, two CoR signatures were associated with HIV risk after adjustment for known behavioral and clinical risk factors. We identified host gene expression signatures associated with HIV acquisition, but the observed effects are likely not mediated through Mtb infection. Public Library of Science 2022-05-03 /pmc/articles/PMC9064099/ /pubmed/35503767 http://dx.doi.org/10.1371/journal.pone.0267729 Text en © 2022 Bender Ignacio et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bender Ignacio, Rachel A.
Long, Jessica
Saha, Aparajita
Nguyen, Felicia K.
Joudeh, Lara
Valinetz, Ethan
Mendelsohn, Simon C.
Scriba, Thomas J.
Hatherill, Mark
Janes, Holly
Churchyard, Gavin
Buchbinder, Susan
Duerr, Ann
Shah, Javeed A.
Hawn, Thomas R.
Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
title Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
title_full Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
title_fullStr Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
title_full_unstemmed Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
title_short Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
title_sort mycobacterium tuberculosis infection, immune activation, and risk of hiv acquisition
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064099/
https://www.ncbi.nlm.nih.gov/pubmed/35503767
http://dx.doi.org/10.1371/journal.pone.0267729
work_keys_str_mv AT benderignaciorachela mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT longjessica mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT sahaaparajita mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT nguyenfeliciak mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT joudehlara mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT valinetzethan mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT mendelsohnsimonc mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT scribathomasj mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT hatherillmark mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT janesholly mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT churchyardgavin mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT buchbindersusan mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT duerrann mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT shahjaveeda mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition
AT hawnthomasr mycobacteriumtuberculosisinfectionimmuneactivationandriskofhivacquisition